Eastham JA, Auffenberg GB, Barocas DA, Chou R, Crispino T, Davis JW, et al. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management. J Urol. 2022;208:10–18.

Article  PubMed  Google Scholar 

EAU Guidelines. Edn. presented at the EAU Annual Congress Milan. Arnhem, the Netherlands; EAU Guidelines Office: 2023.

Epstein JI, Zelefsky MJ, Sjoberg DD, Nelson JB, Egevad L, Magi-Galluzzi C, et al. A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. Eur Urol. 2016;69:428–35.

Article  PubMed  Google Scholar 

Ham WS, Chalfin HJ, Feng Z, Trock BJ, Epstein JI, Cheung C, et al. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer. Eur Urol. 2017;71:907–12.

Article  PubMed  Google Scholar 

Briganti A, Abdollah F, Nini A, Suardi N, Gallina A, Capitanio U, et al. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection. Eur Urol. 2012;61:1132–8.

Article  PubMed  Google Scholar 

Shen G, Deng H, Hu S, Jia Z. Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis. Skelet Radio. 2014;43:1503–13.

Article  Google Scholar 

Bjurlin MA, Turkbey B, Rosenkrantz AB, Gaur S, Choyke PL, Taneja SS. Imaging the High-risk Prostate Cancer Patient: Current and Future Approaches to Staging. Urology. 2018;116:3–12.

Article  PubMed  Google Scholar 

Van Nieuwenhove S, Van Damme J, Padhani AR, Vandecaveye V, Tombal B, Wuts J, et al. Whole-body magnetic resonance imaging for prostate cancer assessment: Current status and future directions. J Magn Reson Imaging. 2022;55:653–80.

Article  PubMed  Google Scholar 

Cruz IAN, Fayad LM, Ahlawat S, Lederman HM, Nico MAC, Ormond Filho AG, et al. Whole-Body MRI in Musculoskeletal Oncology: A Comprehensive Review with Recommendations. Radio Imaging Cancer. 2023;5:e220107.

Article  Google Scholar 

Barkhausen J, Quick HH, Lauenstein T, Goyen M, Ruehm SG, Laub G, et al. Whole-body MR imaging in 30 seconds with real-time true FISP and a continuously rolling table platform: feasibility study. Radiology. 2001;220:252–6.

Article  PubMed  CAS  Google Scholar 

Gruber B, Froeling M, Leiner T, Klomp DWJ. RF coils: A practical guide for nonphysicists. J Magn Reson Imaging. 2018;48:590–604.

Article  PubMed  PubMed Central  Google Scholar 

Lauenstein TC, Goehde SC, Herborn CU, Goyen M, Oberhoff C, Debatin JF, et al. Whole-body MR imaging: evaluation of patients for metastases. Radiology. 2004;233:139–48.

Article  PubMed  Google Scholar 

de Rooij M, Hamoen EH, Witjes JA, Barentsz JO, Rovers MM. Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis. Eur Urol. 2016;70:233–45.

Article  PubMed  Google Scholar 

Pasoglou V, Larbi A, Collette L, Annet L, Jamar F, Machiels JP, et al. One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): toward an upfront simplified “all-in-one” imaging approach? Prostate. 2014;74:469–77.

Article  PubMed  CAS  Google Scholar 

Anttinen M, Ettala O, Malaspina S, Jambor I, Sandell M, Kajander S, et al. A Prospective Comparison of (18)F-prostate-specific Membrane Antigen-1007 Positron Emission Tomography Computed Tomography, Whole-body 1.5 T Magnetic Resonance Imaging with Diffusion-weighted Imaging, and Single-photon Emission Computed Tomography/Computed Tomography with Traditional Imaging in Primary Distant Metastasis Staging of Prostate Cancer (PROSTAGE). Eur Urol Oncol. 2021;4:635–44.

Article  PubMed  Google Scholar 

Johnston EW, Latifoltojar A, Sidhu HS, Ramachandran N, Sokolska M, Bainbridge A, et al. Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging. Eur Radio. 2019;29:3159–69.

Article  Google Scholar 

Lecouvet FE, El Mouedden J, Collette L, Coche E, Danse E, Jamar F, et al. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol. 2012;62:68–75.

Article  PubMed  Google Scholar 

Dyrberg E, Hendel HW, Huynh THV, Klausen TW, Logager VB, Madsen C, et al. (68)Ga-PSMA-PET/CT in comparison with (18)F-fluoride-PET/CT and whole-body MRI for the detection of bone metastases in patients with prostate cancer: a prospective diagnostic accuracy study. Eur Radiol. 2019;29:1221–30.

Larbi A, Omoumi P, Pasoglou V, Michoux N, Triqueneaux P, Tombal B, et al. Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences. Eur Radio. 2019;29:4503–13.

Article  Google Scholar 

Saylor B. PSMA uptake, access appear high for US-based urologists. Urology Times. 2023. https://www.urologytimes.com/view/psma-uptake-access-appearhigh-for-us-based-urologists.

Manafi-Farid R, Ranjbar S, Jamshidi Araghi Z, Pilz J, Schweighofer-Zwink G, Pirich C, et al. Molecular Imaging in Primary Staging of Prostate Cancer Patients: Current Aspects and Future Trends. Cancers. 2021;13:5360.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Budaus L, Leyh-Bannurah SR, Salomon G, Michl U, Heinzer H, Huland H, et al. Initial Experience of (68)Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy. Eur Urol. 2016;69:393–6.

Article  PubMed  Google Scholar 

Costelloe CM, Madewell JE, Kundra V, Harrell RK, Bassett RL Jr, Ma J. Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: clinical utility per sequence. Magn Reson Imaging. 2013;31:669–75.

Article  PubMed  PubMed Central  Google Scholar 

Ma J, Costelloe CM, Madewell JE, Hortobagyi GN, Green MC, Cao G, et al. Fast dixon-based multisequence and multiplanar MRI for whole-body detection of cancer metastases. J Magn Reson Imaging. 2009;29:1154–62.

Article  PubMed  Google Scholar 

Asa S, Ozgur E, Uslu-Besli L, Ince B, Sager S, Demirdag C, et al. Hybrid Ga-68 prostate-specific membrane antigen PET/MRI in the detection of skeletal metastasis in patients with newly diagnosed prostate cancer: Contribution of each part to the diagnostic performance. Nucl Med Commun. 2023;44:65–73.

Article  PubMed  CAS  Google Scholar 

Thalgott M, Duwel C, Rauscher I, Heck MM, Haller B, Gafita A, et al. One-Stop-Shop Whole-Body (68)Ga-PSMA-11 PET/MRI Compared with Clinical Nomograms for Preoperative T and N Staging of High-Risk Prostate Cancer. J Nucl Med. 2018;59:1850–6.

Article  PubMed  CAS  Google Scholar 

DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45.

Article  PubMed  CAS  Google Scholar 

Abuzallouf S, Dayes I, Lukka H. Baseline staging of newly diagnosed prostate cancer: a summary of the literature. J Urol. 2004;171:2122–7.

Article  PubMed  Google Scholar 

Surasi DS, Eiber M, Maurer T, Preston MA, Helfand BT, Josephson D, et al. Diagnostic Performance and Safety of Positron Emission Tomography with (18)F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE). Eur Urol. 2023;84:361–70.

Article  PubMed  CAS  Google Scholar 

Van Damme J, Tombal B, Collette L, Van Nieuwenhove S, Pasoglou V, Gerard T, et al. Comparison of (68)Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI) with Diffusion Sequences (DWI) in the Staging of Advanced Prostate Cancer. Cancers. 2021;13:5286.

Article  PubMed  PubMed Central  Google Scholar 

Kaufmann S, Kruck S, Gatidis S, Hepp T, Thaiss WM, Hennenlotter J, et al. Simultaneous whole-body PET/MRI with integrated multiparametric MRI for primary staging of high-risk prostate cancer. World J Urol. 2020;38:2513–21.

Article  PubMed  CAS  Google Scholar